Mercer Global Advisors
UTMD icon

Mercer Global Advisors’s Utah Medical Products UTMD Stock Holding History

Mercer Global Advisors’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$595K Sell
8,633
-245
-3% -$16.3K ﹤0.01% 2139
2026
Q1 		$550K Buy
8,878
+1,073
+14% +$67.6K ﹤0.01% 1916
2025
Q4 		$437K Buy
7,805
+478
+7% +$27.7K ﹤0.01% 1958
2025
Q3 		$461K Buy
7,327
+2,798
+62% +$166K ﹤0.01% 1799
2025
Q2 		$258K Sell
4,529
-82
-2% -$4.46K ﹤0.01% 1935
2025
Q1 		$258K Buy
4,611
+261
+6% +$15.6K ﹤0.01% 1837
2024
Q4 		$267K Hold
4,350
– – ﹤0.01% 1817
2024
Q3 		$287K Hold
4,350
– – ﹤0.01% 1631
2024
Q2 		$291K Sell
4,350
-10
-0.2% -$681 ﹤0.01% 1590
2024
Q1 		$310K Sell
4,360
-28
-0.6% -$2.1K ﹤0.01% 1546
2023
Q4 		$370K Sell
4,388
-10
-0.2% -$829 ﹤0.01% 1493
2023
Q3 		$378K Buy
4,398
+48
+1% +$4.43K ﹤0.01% 1397
2023
Q2 		$405K Sell
4,350
-129
-3% -$12.2K ﹤0.01% 1336
2023
Q1 		$424K Sell
4,479
-5,202
-54% -$478K ﹤0.01% 1293
2022
Q4 		$973K Sell
9,681
-17
-0.2% -$1.55K ﹤0.01% 932
2022
Q3 		$827K Hold
9,698
– – ﹤0.01% 926
2022
Q2 		$833K Hold
9,698
– – 0.01% 923
2022
Q1 		$871K Hold
9,698
– – 0.01% 950
2021
Q4 		$970K Buy
9,698
+110
+1% +$11.2K 0.01% 899
2021
Q3 		$890K Hold
9,588
– – 0.01% 916
2021
Q2 		$815K Hold
9,588
– – 0.01% 931
2021
Q1 		$830K Buy
+9,588
New +$843K 0.01% 864

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mercer Global Advisors's UTMD Position: Q2 2026 in Review

Mercer Global Advisors reduced its Utah Medical Products (UTMD) stake by 2.8% in Q2 2026, selling an estimated $16.3K and leaving 8,633 shares worth $595K. The position accounts for ﹤0.01% of the portfolio, ranked #2139.

Mercer Global Advisors first reported a position in UTMD in Q1 2021 and has held it in 22 quarters since. The position peaked at $973K in Q4 2022. 114 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • Mercer Global Advisors held 8,633 shares of Utah Medical Products worth $595K as of Q2 2026.
  • Mercer Global Advisors sold 245 Utah Medical Products shares in Q2 2026, an estimated $16.3K.
  • Utah Medical Products made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2139 holding.
  • Mercer Global Advisors first reported a position in Utah Medical Products in Q1 2021 and has held it in 22 quarters since.
  • Mercer Global Advisors's Utah Medical Products position peaked at $973K in Q4 2022.
  • 114 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.